On July 21st, digital medical company AristaMD announced the completion of a $11 million Series A round of financing, led by Avalon Ventures, and Correlation Ventures. The company plans to use this financing to promote the commercialization process and further develop the company's intelligent recommendation platform.
Founded in 2014 and headquartered in La Jolla, Calif., AristaMD's proprietary smart recommendation platform is designed by licensed physicians, combining clinical guidelines developed by the University of California, San Francisco (USFC) with a simple, efficient professional eConsult platform. . At present, up to 60% of expert visits are routine routine consultations, but experts do not need to be present in person. This type of consultation generates approximately $10 billion annually and delays other care plans, making it more difficult for high-risk patients to receive timely care. AristaMD's intelligent recommendation platform is user-friendly and has core electronic medical record interoperability that promotes collaboration between primary caregivers and professional physicians, optimizes professional care services, and reduces unnecessary expert recommendations, significantly reducing the cost of care. AristaMD's client range includes small rural healthcare providers to large county-level healthcare systems, so the platform is designed to be flexible enough to accommodate each individual client workflow, technology and clinical needs. AristaMD's solution has been proven to reduce the rate of expert visits by 30% and to reduce emergency visits and hospitalization rates.
Antimicrobial Central Venous Catheter
Central Venous Catheter,CVC,central venous catheter set,central venous catheter double lumen,central venous catheter kit
Anesthesia Medical Co., Ltd. , https://www.honestymed.com